Modulation of Doxorubicin Actions in Hepatocellular Carcinoma Cells by Insulin-Like Growth Factor-I

Maria Grazia Refolo¹, Rosalba D’Alessandro¹, Catia Lippolis¹, Nicola Carella¹, Caterina Messa¹, Aldo Cavallini¹ and Brian Irving Carr^2*

¹Department of Clinical Pathology, Laboratory of Cellular and Molecular Biology, National Institute for Digestive Diseases, IRCCS “Saverio de Bellis”, Via Turi 27, 70013, Castellana Grotte, BA, Italy

²Program for Targeted Experimental Therapeutics, Izmir Biomedicine and Genome Center, Dokuz Eylul University, Izmir, Turkey